Search Results for "Colchicine And Rivaroxaban"

22:31 EDT 22nd August 2017 | BioPortfolio

Matching Channels


Rivaroxaban is the most broadly indicated novel oral anticoagulant and is marketed under the brand name Xarelto®. To date, Xarelto has been approved for use in the following indications across t...

Matching News

Rivaroxaban vs. Warfarin in a Patient With AF and LAA Thrombus

This case highlights the possibility of using rivaroxaban as a safe and effective alternative to warfarin in complex cases involving certain thrombophilic conditions. Journal of Medical Case Reports

Rivaroxaban OK for stroke prevention in cancer patients

(HealthDay)—The safety and efficacy of rivaroxaban treatment for nonvalvular atrial fibrillation (AF) in patients with active cancer is similar to the general population, according to a study publis...

Global Rivaroxaban Market Research Report Forecast 2017 to 2022 [Report Updated: 29062017] Prices from USD $2800

Delivery of the Report will take 23 working days once order is placed.The Global Rivaroxaban Market Research Report Forecast 20172022 is a valuable source of insightful data for business strategists....

Human medicines European public assessment report (EPAR): Xarelto, rivaroxaban, Revision: 20, Authorised

Human medicines European public assessment report (EPAR): Xarelto, rivaroxaban, Revision: 21, Authorised

Redefining Acute Coronary Syndrome Therapy

Patients with acute coronary syndromes who received a low dose of the oral anticoagulant rivaroxaban, when substituted for aspirin in dual antiplatelet therapy (DAPT), had a similar risk of clinically...

Janssen R&D Release: U.S. FDA Grants Priority Review Of XARELTO (Rivaroxaban) sNDA For A 10 Mg Dose To Reduce The Risk Of Recurrent Venous Thromboembolism (VTE)

  Life Sciences Jobs   ...

Janssen Pharmaceutical Release: New XARELTO (Rivaroxaban) Data At Congress 2017 Includes Late-Breaking Results From Landmark Phase III COMPASS Study

  Life Sciences Jobs   ...

Matching PubMed Articles

Potential anticancer role of colchicine-based derivatives: an overview.

Colchicine, the main alkaloid of the poisonous plant meadow saffron (Colchicum autumnale L.), is a classical drug used for the treatment of gout and familial Mediterranean fever. Although colchicine i...

Microbial Catalyzed Regio-Selective Demethylation of Colchicine by Streptomyces griseus ATCC 13273.

Colchicinoids and their derivatives are of great importance in pharmaceutical applications, and colchicine is usually used as the first choice for the treatment of gout. To expand the structural diver...

Prolongation of prothrombin time in the presence of rivaroxaban: is this the only cause?

Rivaroxaban is an oral direct Xa inhibitor that can lead to prolongation of prothrombin time and activated partial thromboplastin time. However, these basic coagulation tests are not specific for the ...

Colchicine in Renal Medicine: New Virtues of an Ancient Friend.

Colchicine is a plant-derived alkaloid that disrupts the cell microtubule system and accumulates in neutrophils, inhibiting neutrophil adhesion and recruitment. Colchicine has been used extensively in...

Interleukin-8 enhances the effect of colchicine on cell death.

Pro-inflammatory cytokines are known to be generated in tumors and play important roles in angiogenesis, mitosis, and tumor progression. However, few studies have investigated the synergistic effects ...

Search Whole site using Google

Quick Search
Advertisement Advertisement